title: [Borderline personality disorders: diagnosis and treatment].
abstract: Borderline personality disorders are complex clinical states with highly polymorphic symptoms and signs, leading to delays in their diagnosis and treatment. All international classifications emphasize certain clinical criteria such as unstable identity and interpersonal relationships, feelings of emptiness or boredom, and pathological impulsiveness. The prevalence is about 2%, with a female-male sex ratio of 2 or 3 to 1. Both adolescents and adults may be affected There is a high risk of suicide, addictive behaviors, eating disorders, and criminality. These individuals frequently have a history of trauma in early childhood, such as separation, loss, physical or sexual abuse, or affective privation. Subjective signs and symptoms are particularly important in the diagnostic and therapeutic evaluation, and this requires an empathic and subtle approach. Standardized and semi-structured interviews may help to identify comorbidities such as thymic disorders, anxiety, addiction, eating disorders, and, in some cases, psychotic symptoms. The psychiatric bio-psycho-social model takes into account multiple pathogenic factors, such as trauma during early development, temperamental instability and other emotional disorders, as well as psychosocial, neurobiological (5HT etc.) and genetic vulnerabilities. Treatment requires optimal integration of psychotherapeutic and pharmacotherapeutic approaches. Emergency intervention must be available in case of delirious or suicidal behavior The clinical course is often lengthy and complex, but outcome may be favorable, provided the principal risk--suicide--is correctly managed,
authors.affiliation: L'Académie nationale de médecine, Hôpital de la Pitié-Salpêtrière, Pôle des maladies du système nerveux, 47-83 bd de l'Hôpital-75013 Paris. jf.allilaire@psl.aphp.fr
authors.forename: Jean-François
authors.initials: JF
authors.lastname: Allilaire
mesh_terms: D000293:Adolescent; D000328:Adult; D001883:Borderline Personality Disorder / Q000175:diagnosis* / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D015897:Comorbidity; D004644:Emotions; D005260:Female; D006801:Humans; D007175:Impulsive Behavior; D007398:Interpersonal Relations; D008297:Male; D008960:Models, Psychological; D011613:Psychotherapy; D011619:Psychotropic Drugs / Q000627:therapeutic use; D063189:Symptom Assessment; D000092864:Suicide Prevention
chemical_list: D011619:Psychotropic Drugs